Krystal Biotech, Inc. Financial Ratios — KRYS Stock

Profitability (USD)

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-30.29	-13.1	-11.74	-12.38	-14.85	-23.63	1.59	9.51	17.14
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	-4.1	-40.98	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	-12.47	11.05	- -
Gross Margin (%)	- -	- -	- -	- -	- -	- -	- -	93.9	93.09	94.08
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -	- -	-179.9	37.85	43.13
Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	-191.56	35.54	41.45
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	83.55	58.86
Pretax Margin (%)	- -	- -	- -	- -	- -	- -	- -	25.44	32.82	48.69
Profit Margin (%)	- -	- -	- -	- -	- -	- -	- -	21.56	30.69	52.64
Net Income to Common Margin (%)	- -	- -	- -	- -	- -	- -	- -	21.56	30.69	52.64
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	15.24	6.5	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	2	- -	- -	3	12	8	9	8	7	9
ST Debt	- -	- -	- -	- -	8	1	2	1	1	2
LT Debt	2	- -	- -	3	3	7	7	7	6	8
Total Debt/EBITDA	-1.62	- -	- -	-0.16	-0.37	-0.12	-0.08	-0.09	0.07	0.06
Net Debt/EBITDA	0.07	10.44	8.8	8.93	8.61	5.14	1.39	3.93	-3.14	-2.96
Total Debt/EBIT	-1.61	- -	- -	-0.15	-0.35	-0.12	-0.07	-0.08	0.07	0.06
Net Debt/EBIT	0.07	10.39	8.7	8.49	8.13	5	1.35	3.69	-3.34	-3.08
EBITDA to Interest Expense	-163	-1.51	-11.47	- -	- -	-44.52	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	-165.14	-1.58	-13.64	- -	- -	-90.32	- -	- -	- -	- -
EBIT to Interest Expense	-163.29	-1.52	-11.6	- -	- -	-45.76	- -	- -	- -	- -
Interest Expense	- -	3	1	- -	- -	1	- -	- -	- -	- -
Common Equity/Total Assets	-52.7	-18.1	-17.19	-18.68	-22.91	-22.48	-50.27	-32.97	-17.11	1.81
Long-Term Debt/Equity (%)	637.72	- -	- -	1.37	1.13	1.18	1.41	0.85	0.64	0.62
Long-Term Debt/Capital (%)	87.8	- -	- -	-7.77	-5.54	-5.26	-2.71	-2.53	-3.49	22.59
Long-Term Debt/Total Assets (%)	84.46	- -	- -	1.33	1.06	1.11	1.32	0.81	0.57	0.57
Total Debt/Equity (%)	637.72	- -	- -	1.61	3.95	1.35	1.71	1.04	0.77	0.77
Total Debt/Capital (%)	87.8	- -	- -	-9.12	-19.35	-6.04	-3.29	-3.09	-4.19	27.88
Total Debt/Total Assets (%)	84.46	- -	- -	1.56	3.71	1.28	1.6	0.99	0.69	0.7
Net Debt to Equity	-27.68	-100.24	-91.56	-92.41	-91.85	-57.49	-31	-46.02	-36.44	-40.7
Net Debt/Capital (%)	-45.45	84.54	83.86	83.97	81.81	71.99	37.33	57.79	66.54	107.24
EBITDA	-1	-5	-12	-21	-31	-66	-117	-91	110	168
EBITDA-CapEx	-1	-5	-14	-27	-46	-135	-170	-103	106	156
Operating Income (Loss)	-1	-5	-12	-22	-33	-68	-120	-97	103	161

Liquidity (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	44.72	77.49	43.05	58.22	17.56	17.02	13.14	16.08	5.86	8.04
Current Ratio	50.44	77.99	43.39	58.88	17.8	17.18	13.3	17.76	7.28	9.95
Quick Ratio	44.72	77.49	43.05	58.22	17.56	17.02	13.14	17.35	6.89	9.28
CFO/Avg Current Liab	- -	-11.39	-5.84	-6.31	-2.78	-2.33	-3.68	-2.87	1.83	1.96
Common Equity/Total Assets	-52.7	-18.1	-17.19	-18.68	-22.91	-22.48	-50.27	-32.97	-17.11	1.81
Long-Term Debt/Equity (%)	637.72	- -	- -	1.37	1.13	1.18	1.41	0.85	0.64	0.62
Long-Term Debt/Capital (%)	87.8	- -	- -	-7.77	-5.54	-5.26	-2.71	-2.53	-3.49	22.59
Long-Term Debt/Total Assets (%)	84.46	- -	- -	1.33	1.06	1.11	1.32	0.81	0.57	0.57
Total Debt/Equity (%)	637.72	- -	- -	1.61	3.95	1.35	1.71	1.04	0.77	0.77
Total Debt/Capital (%)	87.8	- -	- -	-9.12	-19.35	-6.04	-3.29	-3.09	-4.19	27.88
Total Debt/Total Assets (%)	84.46	- -	- -	1.56	3.71	1.28	1.6	0.99	0.69	0.7
CFO/Total Liabilities	-69.26	-607.81	-326.82	-305.94	-139.04	-146.51	-277.67	-223.61	112.76	175.84
CFO/CapEx	-87.4	-18.52	-4.23	-2.92	-1.76	-0.7	-1.9	-7.53	29.12	16.81
Altman's Z-Score	-1.3	53.48	48.89	86.98	36.38	28.6	32.8	50.92	25.64	39.03

Working Capital (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	2.41	3.96	3.35
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	151.33	92.21	108.89
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	0.89	1.2	0.69
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	412.01	304.69	530.37
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	2.48	8.68	9
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	146.9	42.03	40.54
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	416.44	354.87	598.71
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	-260.68	-212.48	-421.48
Inventories	- -	- -	- -	- -	- -	- -	- -	7	27	40
Raw Materials	- -	- -	- -	- -	- -	- -	- -	3	14	16
Work In Process	- -	- -	- -	- -	- -	- -	- -	3	11	15
Finished Goods	- -	- -	- -	- -	- -	- -	- -	1	2	9
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	56	233	881	1,127	1,553	2,019	3,369	4,479	7,136
- Cash & Cash Equivalents	2	50	104	188	268	341	162	358	345	496
+ Preferred Equity and Hybrid Capital	1	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	2	- -	- -	3	12	8	9	8	7	9
Enterprise Value	1	7	121	690	868	1,123	1,649	2,845	3,889	6,317
Total Capital	2	-9	-20	-36	-60	-133	-272	-262	-173	34
Total Debt/Capital (%)	87.8	- -	- -	-9.12	-19.35	-6.04	-3.29	-3.09	-4.19	27.88
Total Debt / EV	1.39	- -	- -	- -	0.01	0.01	0.01	- -	- -	- -
EV/Sales	- -	- -	- -	- -	- -	- -	- -	56.11	13.39	16.23
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	35.37	37.64
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	37.67	39.17
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	31.51	31.45
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	51.28	- -	- -	30.46	29.68
Diluted Market Cap	- -	56	233	881	1,127	1,553	2,019	3,443	4,659	7,384
Diluted Enterprise Value	1	7	129	696	871	1,219	1,867	3,093	4,321	6,897
EV per Share	0.31	1.27	10.8	43.4	46.18	50.57	64.7	104.76	136.02	218.26
TTM Sales	- -	- -	- -	- -	- -	- -	- -	51	291	389
TTM EBITDA	-1	-5	-12	-21	-31	-66	-117	-91	110	168
TTM Operating Income	-1	-5	-12	-22	-33	-68	-120	-97	103	161
TTM Cash Flow to Firm	-1	-1	-8	-19	-26	-46	-101	-89	123	201
TTM Free Cash Flow to Firm	-1	-1	-6	-12	-11	22	-48	-77	128	213

Multiples (USD)

API Chat

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	-15.32	-32.28	-71.65	-100.29	76.12	-42.43	-44.71	36.5	34.7
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	37.67	39.17
Enterprise Value	1	7	121	690	868	1,123	1,649	2,845	3,889	6,317
Low Price	- -	8.03	8.61	18.5	33.08	38.86	47.67	69.81	107.5	122.8
EV/Sales	- -	- -	- -	- -	- -	- -	- -	56.11	13.39	16.23
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	35.37	37.64
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	308.15	50.24	34.84
Price/Earnings Average	- -	-6.79	-15.15	-31.4	-28.28	-20.7	-12.35	257.07	54.39	23.88
Price/Earnings High	- -	-8.11	-29.58	-55.4	-39.04	-32.86	-15.5	329.56	70.34	37.58
Price/Earnings Low	- -	-5.43	-8.86	-15.41	-19.32	-12.4	-8.68	173.4	34.47	17.35
Price/Book Value	- -	-6.22	-11.66	-22.55	-15.83	-11.03	-7.19	-12.48	-24.79	295.32
Price/Book Value Average	- -	-5.93	-8.26	-15.35	-12.77	-10.23	-6.16	-10.42	-26.84	202.43
Price/Book Value High	- -	-7.08	-16.14	-27.08	-17.64	-16.24	-7.73	-13.35	-34.71	318.54
Price/Book Value Low	- -	-4.75	-4.83	-7.53	-8.73	-6.13	-4.33	-7.03	-17.01	147.1
Price/Tangible Book Value	- -	1.14	2.06	4.34	3.86	2.62	3.87	4.33	4.73	5.85
Price/Tangible Book Value Average	- -	1.09	1.46	2.95	3.11	2.43	3.31	3.61	5.12	4.01
Price/Tangible Book Value High	- -	1.3	2.84	5.21	4.3	3.85	4.15	4.63	6.63	6.31
Price/Tangible Book Value Low	- -	0.87	0.85	1.45	2.13	1.45	2.33	2.43	3.25	2.91
Price/Sales	- -	- -	- -	- -	- -	- -	- -	66.45	15.42	18.34
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	55.43	16.69	12.57
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	71.06	21.59	19.78
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	37.39	10.58	9.13
Price/Cash Flow	- -	-14.5	-24.65	-47.12	-43.22	-32.39	-20.08	-37.93	36.29	35.53
Price/Cash Flow Average	- -	-13.82	-17.47	-32.07	-34.87	-30.03	-17.19	-31.65	39.29	24.35
Price/Cash Flow High	- -	-16.51	-34.1	-56.58	-48.15	-47.69	-21.57	-40.57	50.81	38.32
Price/Cash Flow Low	- -	-11.07	-10.21	-15.74	-23.83	-17.99	-12.08	-21.35	24.9	17.7
Price/Free Cash Flow Average	- -	-14.61	-22.88	-48.76	-80.93	70.58	-36.34	-37.3	39.52	23.78
Price/Free Cash Flow High	- -	-17.45	-44.67	-86.03	-111.74	112.07	-45.59	-47.82	51.1	37.42
Price/Free Cash Flow Low	- -	-11.7	-13.38	-23.93	-55.29	42.29	-25.53	-25.16	25.04	17.28
EV/Sales Average	- -	- -	- -	- -	- -	- -	- -	48.52	15.53	11.32
EV/Sales High	- -	- -	- -	- -	- -	- -	- -	64.15	20.42	18.53
EV/Sales Low	- -	- -	- -	- -	- -	- -	- -	30.48	9.42	7.88
EV/EBITDA Average	-1.16	-0.88	-5.21	-19.77	-20.96	-16.66	-13.49	-26.97	41.03	26.24
EV/EBITDA High	-1.16	-3.08	-18.55	-41.6	-32.08	-29.4	-17.26	-35.66	53.96	42.95
EV/EBITDA Low	-1.16	1.38	0.61	-5.24	-11.71	-7.97	-9.09	-16.94	24.88	18.27
EV/EBIT Average	-1.16	-0.88	-5.14	-18.8	-19.79	-16.21	-13.11	-25.33	43.7	27.31
EV/EBIT High	-1.16	-3.07	-18.33	-39.54	-30.28	-28.6	-16.78	-33.49	57.47	44.7
EV/EBIT Low	-1.16	1.37	0.61	-4.98	-11.05	-7.75	-8.84	-15.91	26.5	19.02
Last Price	- -	10.52	20.78	55.38	60	69.95	79.22	124.06	156.66	246.54
High Price	- -	11.98	28.75	66.5	66.85	102.99	85.11	132.68	219.34	265.92
Enterprise Value Average	1	4	61	415	653	1,107	1,576	2,460	4,512	4,404
Enterprise Value High	1	15	218	873	999	1,953	2,017	3,253	5,934	7,210
Enterprise Value Low	1	-7	-7	110	365	529	1,062	1,545	2,736	3,067

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	10	10	14	17	20	25	26	28	29	29
Diluted Weighted Avg Shares	4	5	11	16	19	22	25	28	30	30
Basic Weighted Avg Shares	4	5	11	16	19	22	25	27	29	29
Revenue per Share	- -	- -	- -	- -	- -	- -	- -	1.87	10.16	13.44
EBITDA per Share	-0.27	-0.89	-1.05	-1.32	-1.66	-2.99	-4.58	-3.36	3.85	5.8
Operating Income per Share	-0.27	-0.89	-1.06	-1.39	-1.76	-3.08	-4.72	-3.58	3.61	5.57
Basic EPS, GAAP	-0.27	-1.48	-0.97	-1.2	-1.71	-3.13	-5.49	0.4	3.12	7.08
Basic EPS from Cont Ops	-0.27	-1.48	-0.97	-1.2	-1.71	-3.13	-5.49	0.4	3.12	7.08
Diluted EPS, GAAP	-0.27	-1.48	-0.97	-1.2	-1.71	-3.13	-5.49	0.39	3	6.84
Diluted EPS from Cont Ops	-0.27	-1.48	-0.97	-1.2	-1.71	-3.13	-5.49	0.39	3	6.84
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.31	-0.73	-0.84	-1.18	-1.39	-2.16	-3.95	-3.27	4.32	6.94
Free Cash Flow per Basic Share	-0.31	-0.76	-1.04	-1.58	-2.18	-5.24	-6.02	-3.7	4.17	6.53
Cash & Equivalents per Share	0.45	9.25	9.98	12.18	14.44	19.74	14.87	19.6	20.9	28.6
Book Value per Share	-0.27	-1.69	-1.78	-2.46	-3.79	-6.34	-11.01	-9.94	-6.32	0.83
Tangible Book Value per Share	-0.26	9.23	10.11	12.76	15.55	26.74	20.49	28.68	33.1	42.14

Krystal Biotech, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)